TrialDiabetes, obesity & metabolism2016

Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin-angiotensin blockers.

H J L Heerspink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.